Interestingly, a study on 197 AML patients showed in the subset analysis that PD-L1 expression is associated with the adverse group based on molecular biology and/or cytogenetics, and it is negatively correlated with TP53 [122]. The gene discussed is CD274; the disease is acute myeloid leukemia.